EndeavorOTC®: Outplay ADHD

The description of EndeavorOTC®: Outplay ADHD

Site Editorial Commentary：The only FDA-authorized digital therapeutic for ADHD without a prescription.

Start your journey towards better focus and attention with EndeavorOTC®, a cutting-edge, game-based ADHD treatment, now available by subscription—no prescription needed! Clinically designed to improve ADHD symptoms, attention, and focus in adults, EndeavorOTC® utilizes the same innovative technology as the world’s first FDA-authorized game-based treatment, EndeavorRx.

EndeavorOTC® is specifically designed for adults aged 18 and older who experience inattention-related challenges impacting their daily lives. If you struggle with diminished focus, have difficulty completing tasks or projects, or often misplace important items, EndeavorOTC® may be the solution you've been seeking. Track your progress with Focus Score, a unique personalized metric designed to monitor your attention improvements over time.

In a rigorous 6-week clinical trial involving over 220 participants, EndeavorOTC® demonstrated remarkable results. An impressive 88% of participants experienced significant improvements in attention, while 73% reported enhanced quality of life, including increased ability to manage projects, meet deadlines, and keep track of essential items. Importantly, the clinical trials revealed no lasting or serious side effects.(1,2)

EndeavorOTC® works by engaging you in gameplay that challenges you to tap targets and navigate obstacles, effectively boosting your attention and focus. The adaptive algorithms continuously measure your performance, dynamically adjusting the difficulty to personalize the treatment experience and optimize your cognitive training.

Integrating EndeavorOTC® into your daily routine is easy. Consistent gameplay is key to achieving optimal results. Playing the game daily for an initial six weeks can lead to noticeable improvements in attention and other cognitive functions crucial for maintaining focus. Users are given a target Focus Score increase which should be achievable in six weeks. Clinical trial data suggests that achieving the target increase directly correlates with improvement in ADHD-related symptoms and overall quality of life. Furthermore, most individuals can expect continued improvement in their Focus Score, cognitive abilities, and ADHD symptom management beyond the initial six-week treatment period.

We recommend consulting with your healthcare provider before starting EndeavorOTC® treatment or making any medical decisions.

© 2025 Akili Interactive Labs, Inc. All Rights Reserved. Akili, EndeavorRx, Endeavor, Akili Care, ADHD Insight, Insight, EndeavorRx Insight, EndeavorOTC, SSME, and Akili Assist, as well as the logos for each, are trademarks or registered trademarks of Akili Interactive Labs, Inc. Other trademarks are trademarks or registered trademarks of their respective owners.

For full instructions for use, please visit https://www.endeavorotc.com/IFU/.
For more information, visit EndeavorOTC.com.
Questions? email [email protected]

Terms of Use: https://my.akili.care/terms
Privacy Notice: https://www.akiliinteractive.com/privacy-notice

1 Stamatis, C. A., Mercaldi, C., & Kollins, S. H., J Am Acad Child Adolesc Psychiatry, 62, S318 (2023). As measured by average percent change in the Test of Variables of Attention-Attention Comparison Score (TOVA-ACS).
2 As measured by the validated Adult ADHD Quality of Life Scale (AAQoL)